Hostname: page-component-74656f9884-rngvg Total loading time: 0 Render date: 2026-11-05T21:40:46.586Z Has data issue: false hasContentIssue false

Intramuscular fat content in meat-producing animals: development, genetic and nutritional control, and identification of putative markers

Published online by Cambridge University Press:  23 October 2009

J. F. Hocquette*
Affiliation:
INRA, UR 1213, Unité de Recherches sur les Herbivores (URH), Theix, F-63122 Saint-Genès Champanelle, France
F. Gondret
Affiliation:
INRA, UMR 1079, Systèmes d’élevage, Nutrition Animale et Humaine (SENAH), F-35590 Saint Gilles, France
E. Baéza
Affiliation:
INRA, UR 83, Unité de Recherches Avicoles (URA), F-37380 Nouzilly, France
F. Médale
Affiliation:
INRA, UMR 1067, Nutrition Aquaculture et Génomique (NUAGE), Pôle Hydrobiologie INRA, F-64310, Saint-Pée-sur-Nivelle, France
C. Jurie
Affiliation:
INRA, UR 1213, Unité de Recherches sur les Herbivores (URH), Theix, F-63122 Saint-Genès Champanelle, France
D. W. Pethick
Affiliation:
School of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia 6150, Australia

Abstract

Intramuscular fat (IMF) content plays a key role in various quality traits of meat. IMF content varies between species, between breeds and between muscle types in the same breed. Other factors are involved in the variation of IMF content in animals, including gender, age and feeding. Variability in IMF content is mainly linked to the number and size of intramuscular adipocytes. The accretion rate of IMF depends on the muscle growth rate. For instance, animals having a high muscularity with a high glycolytic activity display a reduced development of IMF. This suggests that muscle cells and adipocytes interplay during growth. In addition, early events that influence adipogenesis inside the muscle (i.e proliferation and differentiation of adipose cells, the connective structure embedding adipocytes) might be involved in interindividual differences in IMF content. Increasing muscularity will also dilute the final fat content of muscle. At the metabolic level, IMF content results from the balance between uptake, synthesis and degradation of triacylglycerols, which involve many metabolic pathways in both adipocytes and myofibres. Various experiments revealed an association between IMF level and the muscle content in adipocyte-type fatty acid-binding protein, the activities of oxidative enzymes, or the delta-6-desaturase level; however, other studies failed to confirm such relationships. This might be due to the importance of fatty acid fluxes that is likely to be responsible for variability in IMF content during the postnatal period rather than the control of one single pathway. This is evident in the muscle of most fish species in which triacylglycerol synthesis is almost zero. Genetic approaches for increasing IMF have been focused on live animal ultrasound to derive estimated breeding values. More recently, efforts have concentrated on discovering DNA markers that change the distribution of fat in the body (i.e. towards IMF at the expense of the carcass fatness). Thanks to the exhaustive nature of genomics (transcriptomics and proteomics), our knowledge on fat accumulation in muscles is now being underpinned. Metabolic specificities of intramuscular adipocytes have also been demonstrated, as compared to other depots. Nutritional manipulation of IMF independently from body fat depots has proved to be more difficult to achieve than genetic strategies to have lipid deposition dependent of adipose tissue location. In addition, the biological mechanisms that explain the variability of IMF content differ between genetic and nutritional factors. The nutritional regulation of IMF also differs between ruminants, monogastrics and fish due to their digestive and nutritional particularities.

Information

Type
Full Paper
Copyright
Copyright © The Animal Consortium 2009
Figure 0

Figure 1 Overview of energy metabolism in muscular or adipose cells. Lipogenesis (right) is a major metabolic pathway in adipose cells. Mitochondrial oxidation is a major pathway in oxidative muscle fibres. ACC = acetyl-CoA carboxylase; COX = cytochrome-c oxydase; CPT-I = carnitine palmitoyl-transferase-I; CS = citrate synthase; ME: malic enzyme; H- or A-FABP = fatty acid-binding protein (H-FABP: heart and muscle isoform; A-FABP: adipocyte-isoform); FAS = fatty-acid synthase; G3PDH = glycerol-3 phosphate dehydrogenase; G6PDH = glucose-6-phosphate dehydrogenase; ICDH = isocitrate dehydrogenase; HAD = hydroxyacyl-CoA dehydrogenase; LDH = lactate dehydrogenase; LPL = lipoprotein lipase; PDH = pyruvate dehydrogenase; PFK = phosphofructokinase; TG = triglycerides.

Figure 1

Figure 2 Evolution with age of lipid level and the relative area occupied by adipocytes on cross-sections of breast muscle from mule duck (Chartrin et al., 2007).

Figure 2

Figure 3 Relative levels of muscle triglyceride contents, of oxidative and glycolytic metabolic enzymes in muscles fibres and of A-FABP protein expression in rectus abdominis muscle (left) and semitendinosus muscle (right) in Limousine steers (dot lines) and cross-bred Angus × Japanese Black steers (full lines). It is noteworthy that the red oxidative muscle (r. abdominis) has more A-FABP and contains more IMF than the fast-glycolytic muscle (semitendinosus). Differences between genotypes are higher for the red oxidative muscle (r. abdominis) than for the fast-glycolytic one (semitendinosus). Adapted from Jurie et al. (2007). COX = cytochrome-c oxydase; CS = citrate synthase; A-FABP = fatty acid-binding protein (A-FABP: adipocyte-isoform); ICDH = isocitrate dehydrogenase; HAD = hydroxyacyl-CoA dehydrogenase; LDH = lactate dehydrogenase; LPL = lipoprotein lipase; PFK = phosphofructokinase; TG = triglycerides.